The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-10-01

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to explore the correlation between postoperative recovery of liver function and gut microbiota in patients with hepatocellular carcinoma (HCC). Liver resection patients were divided into the recovery group and the recovery delay group according to the recovery level of liver function on the fifth day after the operation. Benign liver disease was used as a control. Statistical analysis was performed to compare the differences in gut microbiota between the three groups. Then, fecal microbiota transplantation was performed in a mouse hepatectomy model. Through this study, the investigators hope to understand the relationship between gut microbiota and postoperative recovery of liver function in patients with hepatocellular carcinoma, so as to provide a new therapeutic direction for patients in the aspect of perioperative liver function recovery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Dietary Intervention and Gut Microbiota in Hepatocellular Carcinoma (HCC)

NCT07143955

Hepatocellular Carcinoma (HCC)

COMPLETED NA

A Clinical Study to Evaluate the Clinical Outcomes of Hepatectomy With Nutritional Risk After Preoperative Nutritional Support

NCT01292330

Liver Cancer

UNKNOWN NA

Influence of Probiotics Administration Before Liver Resection in Liver Disease

NCT02021253

Liver Fibrosis Liver Cirrhosis Permeability; Increased +1 more

COMPLETED NA

Effect of Gastrectomy on Gut Microbiome and Cognitive Function

NCT06186089

Perioperative Neurocognitive Disorders Gastric Cancer

RECRUITING

The Efficacy of Preoperative Oral Administration of Lactobacillus Reuteri Combined With Preoperative Neoadjuvant/Conversion Immunotherapy in Patients With Primary Resectable Liver Cancer

NCT07306481

HCC - Hepatocellular Carcinoma

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. At present, surgery is the first choice and the most effective way to treat it. Based on the case review, the investigators found that the recovery rate of perioperative liver function was correlated with survival. Therefore, it is of great clinical significance to improve the recovery rate of postoperative liver function. Gut microbiota participate in many physiological activities of human body, such as metabolic regulation, immune homeostasis and hormone regulation. However, gut microbiota imbalance, excessive growth of pathogenic microorganisms and changes in intestinal mucosal permeability lead to intestinal bacterial ectopia and bacterial metabolites entering the liver through enterohepatic circulation. The continuous inflammatory stimulation aggravate the progress of liver disease. Therefore, it is helpful to explore the influence of gut microbiota on postoperative liver function recovery and find out the different microbiota, in order to improve the postoperative liver function recovery rate, shorten the perioperative hospital stay and prolong the survival of patients.

According to the recovery level of liver function on the fifth day after the operation, liver resection patients on HCC were divided into the recovery group and the recovery delay group which comparing on the time point of before the surgery and five days after the surgery. The patients on benign liver disease were used as a control. The investigators attempt to identify the differential microbiota and validate this finding in a mouse hepatectomy model.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gut Microbiota Hepatocellular Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Recovery Group

The liver function of HCC patients on the fifth day after the operation is recovered.

No interventions assigned to this group

Recovery Delay Group

The liver function of HCC patients on the fifth day after the operation is delayed recovered.

No interventions assigned to this group

Control Group

The patients on benign disease of the liver

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient is diagnosed with liver cancer by b-mode ultrasonography before the surgery.
* There is no antibiotic treatment, no severe diarrhea and regular diet within two weeks before the surgery.
* It perform laparoscopic or open hepatectomy.
* The postoperative pathological diagnosis is hepatocellular carcinoma.

Exclusion Criteria

* No hepatectomy is performed during the operation.
* The patient is't hepatocellular carcinoma due to the postoperative pathological diagnosis.
* No stool samples are collected during the perioperative period.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes